Gregory L. Shiferman's most recent trade in Sage Therapeutics Inc was a trade of 28,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 28,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 23,735 | 0 (0%) | 0% | - | Common Stock | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | 31 Jul 2025 | 7,215 | 0 (0%) | 0% | - | Common Stock | ||
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. | 24 Jun 2025 | 79 | 30,950 (0%) | 0% | 9.2 | 728 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 525 | 31,205 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Apr 2025 | 176 | 31,029 (0%) | 0% | 6.9 | 1,216 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share. | 24 Mar 2025 | 79 | 30,680 (0%) | 0% | 8.2 | 649 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.49 per share. | 24 Feb 2025 | 2,502 | 30,759 (0%) | 0% | 7.5 | 18,740 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 13 Feb 2025 | 376 | 33,512 (0%) | 0% | 7.2 | 2,700 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 13 Feb 2025 | 251 | 33,261 (0%) | 0% | 7.2 | 1,802 | Common Stock |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to buy) | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 14,000 | 33,888 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | 24 Dec 2024 | 79 | 19,888 (0%) | 0% | 5.5 | 433 | Common Stock | |
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | 01 Nov 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | ||
| Sage Therapeutics Inc | Gregory L. Shiferman | See Remarks | 01 Nov 2024 | 5,000 | 19,967 (0%) | 0% | 0 | Common Stock |